Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada Acquired by Marksans Pharma | Healthcare M&A Deal

Marksans Pharma has acquired Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada, a pharmacy business in Ireland and Canada, for $30 million. Marksans Pharma acquisitions expand the buyer’s European and North American footprint through a strategic acquisition of Teva’s pharmacy operations and product portfolio. The Marksans Pharma acquires Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada acquisition supports healthcare M&A goals by strengthening access to established markets and distribution channels. The add on acquisition is categorized as an add on acquisition and strategic acquisition, with the deal announced and expected to close subject to customary conditions, reinforcing Marksans Pharma acquisitions as a bolt-on strategy in pharmacy.